ASAali Jan Sheen

Aali Jan Sheen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aali Jan Sheen has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Saurabh Jamdar

    Department of Hepatopancreatobiliary Surgery, Manchester University NHS Foundation Trust, Manchester, UK

    7 shared publications
  • Ajith K. Siriwardena

    Regional Hepato-Pancreato-Biliary Surgery Unit, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK; Faculty of Biology, Health and Life Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK

    5 shared publications
  • J. J. Pilkington

    Department of Surgery, Manchester University NHS Foundation Trust, Manchester, UK

    3 shared publications
  • J. James Pilkington

    Department of General Surgery, Manchester Royal Infirmary, Manchester University Foundation Trust, Manchester, United Kingdom

    3 shared publications
  • Minas Baltatzis

    Manchester University Foundation National Health Service (NHS) Trust, Department of Surgery, Manchester, United Kingdom

    3 shared publications
  • Panagiotis Stathakis

    Department of Hepatopancreatobiliary Surgery, Manchester University NHS Foundation Trust, Manchester, UK

    3 shared publications

Latest Publications

  • Open Access

    Innovations in Hepatopancreatobiliary Surgery: A Review of LOTUS-BOWA Liver Blade and AEON Endovascular Stapler

    by Aali Jan Sheen, Jenifer Barrie, Panagiotis Stathakis, Saurabh Jamdar

    Hepatopancreatobiliary (HPB) remains a high-risk but rewarding specialty. This review introduces two innovative surgical instruments that have shown remarkable efficacy in providing safe liver and pancreatic surgery. Both instruments, the LOTUS-Bowa liver energy blade and the AEON endovascular stapler, are discussed in detail, and their respective technologies are presented with emphasis on why their specific innovative designs demonstrate excellent outcomes in use in HPB transectional surgery. In addition, this review shows data on how their respective functionality and ergonomics are suited to HPB and to other gastrointestinal procedures, such as bariatric surgery. Data from two recently published studies are discussed, showing the effectiveness of the use of the LOTUS liver energy device in liver transectional surgery in comparison to open surgery using a matched propensity score. This study demonstrated no difference in blood transfusion using this energy device compared with traditional open surgery methods ( p = 0.348). Comparing the AEON stapler with EndoGIA in pancreatic parenchymal transection undertaken in distal pancreatectomy demonstrated a significant reduction in the fistula rate from 65–20%, as well as showing a more hemostatic staple line requiring no further treatment or intervention. The LOTUS liver blade has promoted an increase in minimally invasive liver transections undertaken with no increase in morbidity. The AEON stapler’s innovative technology has depicted a more secure and hemostatic staple line, especially in use on the pancreatic parenchyma, significantly reducing pancreatic fistula rates.


  • The Sheen Paajanen grOin Recommended Treatment ‘SPoRT’ score for groin pain

    by S. Biswas, J. J. Pilkington, P. Stathakis, S. Jamdar, R. Harwood, H. Paajanen, A. J. Sheen

    Introduction Evaluating groin pain still evades many clinicians at times as they have difficulty determining the cause of pain when no true hernia exists. This study’s aim was to evaluate a simple and novel scoring system which is reproducible, to help determine whether conservative measures or surgery is recommended for the management of groin pain attributable to inguinal disruption. Material & methods A retrospective analysis of all patients from 2018 to 2020 that underwent surgery or conservative management for inguinal disruption with at least a 1-year follow-up were evaluated. The scoring system is based on MRI and ultrasound imaging as well as clinical findings, with scores given from − 2 to + 2 based on the defined findings listed. A maximum total of four points scored for each assessment was used. Sensitivity and specificity analysis was conducted for each potential score cut off point. Results A total of 172 patients were evaluated with 33 patients (19%) undergoing conservative management and 139 patients (81%) undergoing surgery. The median SPoRT score for the surgery group was 2.0 (1.0, 3.0), and − 1.0 (− 3.0, 0.0) in the physiotherapy group which was a significant difference (p < 0.001). An optimal cut off of ≤ 0 for physio and ≥ 1 for surgery was established, yielding a sensitivity of 90.9% (95% CI 75.7%–98.1%), a specificity of 89.2% (95% CI 82.8%–93.8%) and an area under the curve (AUC) of 0.936 (95% CI 0.874–0.997). Discussion SPoRT score of ≤ 0 can recommend a patient should undergo conservative measures or physiotherapy as a mainstay of treatment with a score of ≥ 1 recommending surgery. Further validation of the score is necessary.


  • Open Access

    Preliminary experience in laparoscopic distal pancreatectomy using the AEON™ endovascular stapler

    by Aali J. Sheen, Samik Bandyopadhyay, Minas Baltatzis, Rahul Deshpande, Saurabh Jamdar, Nicola de Liguori Carino

    Background: The aim of this study is to investigate the effects of using a new innovative endovascular stapler, AEON™, on the pancreatic leak rates and other outcome measures.Methods: In a retrospective review of prospectively collected data from a secure tertiary unit registry, patients undergoing distal or lateral pancreatectomy were analyzed for any differences on pancreatic fistula rates, length of stay, comprehensive complication index (CCI), and demographics after using AEON™ compared with other commonly used staplers. Statistical significance was defined as <0.05.Results: There were no differences in the demographics between the two groups totaling 58 patients over 2 years from 2019 to 2021. A total of 43 and 15 patients underwent pancreatic transection using other staplers and AEON™ endovascular stapler, respectively. The comparison of the two groups revealed a significantly reduced rate of mean drain lipase at postoperative day 3 with AEON™ (446 U/L) versus the other staplers (4,208 U/L) (p = 0.018) and a subsequent reduction of postoperative pancreatic fistula (POPF) from 65% to 20%. A reduction in the mean CCI, from 13.80 when other staplers were used to 4.97 when AEON™ was used, was also observed (p = 0.087). Mean length of stay was shorter by 3 days in the AEON™ group compared with that in the other staplers (6 and 9 days, respectively; p = 0.018).Conclusion: AEON™ stapler when used to transect the pancreas demonstrated a significantly reduced pancreatic fistula rate, length of stay in hospital, and a leaning towards a reduced CCI. Its use should be further evaluated in larger cohorts with the encouraging results to determine whether this is possibly related to the technology used in the design of the AEON™ stapler.


  • A fast-track surgery programme leads to timelier treatment and higher resection rates in pancreatic cancer

    by Nicola de Liguori Carino, Minas Baltatzis, Fabio Maroso, Harry V.M. Spiers, Rahul Deshpande, Saurabh Jamdar, Thomas Satyadas, Aali J. Sheen, Ajith K. Siriwardena, Derek A. O'REilly


  • Open Access

    Work-Up and Outcome of Hepatic Resection for Peri-Hilar Cholangiocarcinoma (PH-CCA) without Staging Laparoscopy

    by Santhalingam Jegatheeswaran, Panagiotis Stathakis, Harry V. M. Spiers, Fawwaz Mohammed, Panagiotis Petras, Thomas Satyadas, Michael J. Parker, Angela Lamarca, Saurabh Jamdar, Aali J. Sheen, et al.

    Background: This study reports the outcome of a work-up programme for resection of peri-hilar cholangiocarcinoma (PH-CCA) without the use of staging laparoscopy. Methods: This is a clinical case cohort series of patients undergoing surgical resection of PH-CCA without the use of staging laparoscopy in the work-up algorithm. During the 13 years from 1 January 2009 to 1 January 2022, 32 patients underwent laparotomy for planned surgical resection of PH-CCA. Data were collected on demographic profile, admission biochemistry, radiology, pre-operative intervention, operation and outcome, together with post-operative complications and disease-free and overall survival. Results: All patients underwent pre-operative contrast-enhanced CT. Twenty-four (75%) underwent pre-operative MR. Twenty-three (72%) underwent pre-operative biliary drainage. Twenty-nine patients (91%) had either type III or IV peri-hilar cholangiocarcinoma. One patient (3%) in this series underwent a non-resectional laparotomy. Twenty-nine (91%) had a final histopathological diagnosis of PH-CCA. One further patient had a final diagnosis of an intraductal papillary neoplasm of the biliary tree (IPNB) with high-grade dysplasia but no invasive cancer. Eleven patients (36%) received chemotherapy after surgery. The median (95% CI) time to recurrence was 14 (7–31) months. The median survival was 25 (18-upper limit not reached) months. Conclusion: This cohort of 32 patients undergoing attempted resection for PH-CCA without the use of staging laparoscopy in the work-up algorithm indicates that with careful attention to patient fitness and cross-sectional and interventional radiologic/endoscopic imaging, a very low non-therapeutic laparotomy rate of 3% can be achieved and sustained.

  • Open Access

    Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial

    by Christoph Kuemmerli, Robert S. Fichtinger, Alma Moekotte, Luca A. Aldrighetti, Somaiah Aroori, Marc G. H. Besselink, Mathieu D’hOndt, Rafael Díaz-Nieto, Bjørn Edwin, Mikhail Efanov, et al.

    Background: A shift towards parenchymal-sparing liver resections in open and laparoscopic surgery emerged in the last few years. Laparoscopic liver resection is technically feasible and safe, and consensus guidelines acknowledge the laparoscopic approach in the posterosuperior segments. Lesions situated in these segments are considered the most challenging for the laparoscopic approach. The aim of this trial is to compare the postoperative time to functional recovery, complications, oncological safety, quality of life, survival and costs after laparoscopic versus open parenchymal-sparing liver resections in the posterosuperior liver segments within an enhanced recovery setting. Methods: The ORANGE Segments trial is an international multicentre randomised controlled superiority trial conducted in centres experienced in laparoscopic liver resection. Eligible patients for minor resections in the posterosuperior segments will be randomised in a 1:1 ratio to undergo laparoscopic or open resections in an enhanced recovery setting. Patients and ward personnel are blinded to the treatment allocation until postoperative day 4 using a large abdominal dressing. The primary endpoint is time to functional recovery. Secondary endpoints include intraoperative outcomes, length of stay, resection margin, postoperative complications, 90-day mortality, time to adjuvant chemotherapy initiation, quality of life and overall survival. Laparoscopic liver surgery of the posterosuperior segments is hypothesised to reduce time to functional recovery by 2 days in comparison with open surgery. With a power of 80% and alpha of 0.04 to adjust for interim analysis halfway the trial, a total of 250 patients are required to be randomised. Discussion: The ORANGE Segments trial is the first multicentre international randomised controlled study to compare short- and long-term surgical and oncological outcomes of laparoscopic and open resections in the posterosuperior segments within an enhanced recovery programme. Trial registration: ClinicalTrials.gov NCT03270917. Registered on September 1, 2017. Before start of inclusion. Protocol version: version 12, May 9, 2017


  • Systemic biomarkers currently implicated in the formation of abdominal wall hernia: A systematic review of the literature

    by J.J. Pilkington, T.W. Davies, O. Schaff, M.Y. Alexander, J. Pritchett, F.L. Wilkinson, A.J. Sheen


  • Open Access

    Total extraperitoneal hernia repair and its associated pitfalls

    by Nasra Alam, Aali J. Sheen

    Mini-invasive Surgery is an open access journal, focusing on endoscopy and other minimally invasive procedures research.


  • Totally extraperitoneal repair for the ‘sportsman’s groin’ via ‘the Manchester Groin Repair’: a comparison of elite versus amateur athletes

    by J. J. Pilkington, R. Obeidallah, M. Baltatzis, C. Fullwood, S. Jamdar, A. J. Sheen

    Background Surgery has a recognised role in the treatment of ‘sportsman’s groin’. This study hypothesises that elite athletes have a superior advantage in both pre- and post-op rehabilitation and therefore will present and resume sporting activities quicker. Methods A retrospective analysis on a secure database of athletes presenting with groin pain that underwent surgery for ‘inguinal disruption’. All data were explored via appropriate descriptive statistics and comparisons made between elite and amateur athletes. Results All patients were male (n = 144). The median age 33 years (range 14–72). The median return to sporting activity was 4.5 weeks (range 2.0–16.0) with one amateur athlete being unable to return to sporting activity. Using the mean of both sides, a comparison of VAS pain scores at pre-operative and 1 month post-operative time points showed a significant reduction (p < 0.001). Comparing ‘elite’ versus ‘amateur’ athletes, significant differences were seen in patient age (median 26 vs 40 years; p < 0.001), lead time to clinic presentation (median 62.0 vs 111.5 days; p = 0.004), and time to return to sporting activity (4 vs 5 weeks; p = 0.019). Additional MRI findings within the groin girdle were found in 89 patients (66.4%) and 34 patients (23.6%) had an MRI finding within the adductor tendon. Conclusion The Manchester Groin Rrepair is an effective surgical management for ‘inguinal disruption’. Elite athletes present quicker and return to sport sooner. Given the prevalence of other findings, a multidisciplinary approach to the ‘sportsman’s groin' is required.